News and Announcements
FocusStart Advances to 2017 MN Cup Semi-Finals
- Published July 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
FocusStart has advanced in the Minnesota-based entrepreneurs, inventors and innovators to the semi-finals of the 2017 competition. In its thirteenth year, the MN Cup is giving away $450,000 in seed money, mentorship opportunities with industry leaders, exclusive event access, business plan feedback, networking opportunities with potential investors and media exposure.
KEY TAKEAWAYS:
- FocusStart Respiratory is developing a complete inhaled medication management system to improve patient adherence.
- The company has an innovative health IT solution consists of an inhaler device add-on component that allows communication with smart devices, a patient companion app and a clinician app.
- The add-on component tracks when/where/how the inhaler is used, and measures inhalation and exhalation; and when used with the companion app, the system provides real-time training for proper inhaler use, and supports proper remote lung function testing.
300 million patients suffer from asthma world-wide, morbidity, mortality and healthcare costs are increasing due to poor asthma management. To address these problems, FocusStart have developed Spirit, a comprehensive health IT disease management solution composed of a inhaler add-on medical device connected to patient and provider software applications. This solution will enable better asthma control, and thus reduce healthcare utilization and healthcare costs.